{"id":"W4417009708","doi":"10.1182/blood-2025-5367","title":"Phase 3 study (inMIND) of tafasitamab plus lenalidomide and rituximab for relapsed or refractory follicular lymphoma: Clinical characteristics and outcomes of high-risk patients","year":2025,"lang":"en","type":"article","venue":"Blood","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Spinal Cord Injury BC; University of British Columbia","funders":"","keywords":"Rituximab; Lenalidomide; Follicular lymphoma; Refractory (planetary science); Phases of clinical research; Neutropenia; Placebo; Post-hoc analysis; Dosing; Progression-free survival","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002039875,0.00101538,0.001785703,0.0002926002,0.0004548385,0.0008656296,0.0007876513,0.0007799504,0.002718523],"category_scores_gemma":[0.001012738,0.0004607987,0.001483372,0.0004153172,0.000556109,0.0006830296,0.0004707822,0.00186592,0.0005323995],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009313466,"about_ca_system_score_gemma":0.001389566,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0007404883,"about_ca_topic_score_gemma":0.001523792,"domain_scores_codex":[0.9994788,0.0002647566,0.00003280727,0.00009174285,0.00005501199,0.00007700645],"domain_scores_gemma":[0.9991972,0.00009527314,0.0001875232,0.0000701516,0.00008135695,0.0003685361],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8589332,0.02623282,0.04671108,0.0005398839,0.00302941,0.0002083557,0.0001696099,0.0007697268,0.01393282,0.0001458876,0.002892952,0.0464343],"study_design_scores_gemma":[0.6079824,0.2629223,0.1178141,0.000068735,0.002581211,0.0005141299,0.0001301247,0.001032273,0.002725914,0.0002317524,0.0039457,0.00005134578],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.993427,0.001782287,0.00033065,0.0002520858,0.00005378202,0.00160528,0.001402163,0.00003765032,0.001109025],"genre_scores_gemma":[0.9903157,0.0006361858,0.001232348,0.0006447192,0.0001846689,0.002183028,0.003781705,0.00001530802,0.001006417],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.002718523,"threshold_uncertainty_score":0.01078802,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01942270253737713,"score_gpt":0.3272506070412496,"score_spread":0.3078279045038724,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}